期刊文献+

BRMS1基因蛋白在声门上型喉癌中的表达及临床意义 被引量:5

Expression of gene BRMS1protein in supra-glottic laryngeal carcinoma and its clinical significance
下载PDF
导出
摘要 目的探讨乳腺癌转移抑制基因(breast cancer metastasis suppressor 1,BRMS1)在声门上型喉鳞状细胞癌组织中的表达及其临床意义。方法免疫组化法检测60例原发性声门上型喉癌组织(肿瘤组)和其相邻的癌旁正常喉黏膜(对照组)石蜡标本组织细胞中BRMS1蛋白的表达。结果对照组均有较强的BRMS1蛋白的表达,肿瘤组阳性表达率为35.0%(21/60),且均为低表达,两者之间差异有统计学意义(P<0.05)。BRMS1蛋白在病理高分化标本中阳性表达率为43.6%(17/39),在中、低分化标本阳性表达率19.0%(4/21),两者之间差异有统计学意义(P<0.05);在临床Ⅱ期标本阳性表达率为72.7%(8/11),临床Ⅲ+Ⅳ期标本阳性表达率26.5%(13/49),两者之间差异有统计学意义(P<0.05);颈部淋巴结N0组标本阳性表达率72.7%(16/22),颈部淋巴结N+组阳性率13.7%(5/38),两者之间差异有统计学意义(P<0.05)。BRMS1蛋白阳性组患者与BRMS1蛋白阴性组患者的术后生存率无统计学差异(P>0.05)。结论BRMS1蛋白在声门上型喉癌中低表达或不表达,且其表达可能与声门上型喉癌的临床分期、病理分化以及颈部淋巴结转移有关。 Objective To investigate the expression of breast cancer metastasis suppressor 1 (BRMS1)protein in supra-glottie cancer and to evaluate its clinical significance. Methods The expression of BRMS1 protein was determined by using the immunohistochemical method in 60 cases of paraffin-embeded supraglottic cancer tissues and their surrounding laryngeal normal mucosa tissues(LNT). Results The expression of BRMS1 protein was positive in 35.0%(21/60) cases of carcinoma and 100% (60/60) in LNT, and it was lower in supra-glottic cancer than in normal mucosa, also it was significantly different between supra-glottic cancer tissues and the LNT( P 〈 0.05). The expression of BRMS1 protein in supra-glottic carcinoma was related to the histological grade( P 〈 0. 05), that in a high cell differentiation was 43.6% (17/39) and in a moderate and a low cell differentiation was 19.0% (4/21), and it was related to the clinical stage that in stage Ⅱ was 72.7%(8/11)and in stage Ⅲ-Ⅳ was 26.5%(13/49), also it was related to cervical lymphatic metastasis( P 〈 0.05), that with cervical lymphatic metastasis was 13.7% (5/38) and without cervical lymphatic metastasis was 72.7% (16/22). The 3 and 5-year survival was not significantly different between the positive and the negative groups. Conclusion Expression of BRMS1 protein in supra-glottie cancer is lower than that in normal mueosa. The decrease of BRMS1 protein expression may be related to the clinical stage, low differentiation and cervical lymph node metastasis of supra-glottie cancer.
出处 《山东大学耳鼻喉眼学报》 CAS 2007年第6期481-483,490,F0003,共5页 Journal of Otolaryngology and Ophthalmology of Shandong University
基金 辽宁省自然科学基金资助项目(9522019)
关键词 BRMS1蛋白 喉肿瘤 声门上型 BRMS1 protein Laryngeal neoplasms Supraglottic cancers
  • 相关文献

参考文献12

  • 1Seraj M J, Samant R S, Verderame M F. Ftmctional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13[J]. Cancer Res, 2000, 60(11):2764-2769.
  • 2Shevde L A, Samant R S, Goldberg S F, et al. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMSI[J]. Exp Cell Res, 2002, 273(2):229-239.
  • 3Seraj M J, Harding M A, Gildea J J, et al. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines[ J ]. Clin Exp Metastasis, 2000, 18(6) :519-525.
  • 4张殊,林其德,狄文.BRMS1和fascin基因在卵巢上皮癌中的表达及其意义[J].现代妇产科进展,2003,12(3):167-169. 被引量:24
  • 5Cromer A, Canes A, Millon R, et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis[ J]. Oncogene, 2004, 23(14) : 2484-2498.
  • 6季文樾,于靖寰,关超.声门上型喉癌颈淋巴结隐匿性转移[J].中华耳鼻咽喉科杂志,1999,34(2):111-112. 被引量:28
  • 7王开仕,王薇,朱家珠.喉癌和下咽癌颈淋巴结转移临床对比分析[J].临床耳鼻咽喉科杂志,2003,17(12):711-713. 被引量:6
  • 8Tomik J, Skadzien J, Modrzejewski M, et al. Evaluation of cervical lymph node metastasis of 1400 patients with cancer of the larynx[J]. Auris Nasus Larynx, 2001, 28:233-240.
  • 9Saunders M M, Seraj M J, Li Z, et al. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterespecific gap junctional intercellular communication [J]. Cancer Res, 2001, 61(5) : 1765-1767.
  • 10Kapoor P, Saunders M M, Li Z, et al. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells [ J ]. Int J Cancer, 2004, 111 (5) : 693-697.

二级参考文献22

  • 1李树华,邹连贵,王桂茹,董卫东,贺亚宁,吴岚,宋媛,赵江琪.喉癌颈淋巴结转移相关因素的多元逐步回归分析[J].临床耳鼻咽喉科杂志,1995,9(4):223-225. 被引量:3
  • 2于振坤 王天铎 等.喉癌下咽癌颈廓清组织中转移淋巴结的分布[J].中华耳鼻咽喉科杂志,1998,33:73-75.
  • 3[1]Seraj MJ, Samant RS, Verderame MF, et al. Funcfonal evi dence for a novel human breast carcinoma metastasis suppresor, BRMS1,encoded at chromosome 11q13[J] .Cancer Res, 2000,60:2764-2769
  • 4[2]Weitzel JN, Patel J, Smith DM, et al. Molecular genetic changes associated with ovarian cancer[ J ]. Gynecol Oncol, 1994,55:245-252
  • 5[3]Hu W, Mcrea PD, Deavers M, et al. Increased expression offascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tu mors[J]. Clin Exp Metastasis,2000,18:83-88
  • 6[4]Josephine CA,James DC, G eorgina DM, et al. Cell-matrix ad hesions differentially regulate fascin phosphorylation [ J ]. Mol Biol Cell, 1999,10:4177-4190
  • 7[3]Lukits J, Timar J, Juhasz A,et al. Progression difference between cancers of the larynx and hypopharynx is not due to tumour size and vascularization.Otolaryngol Head Neck Surg,2001,125:18-22.
  • 8[4]Mamelle G, Pampurik J, Lubohski B,et al. Lymph node prognostic factors in head and neck squamous cell carcinomas.Am J Surg,1994,168:494-498.
  • 9[7]dos Santos C R, Goncalves Filho J, Magrin J,et al .Involvement of level I neck lymph node in advanced squamous carcinoma of the larynx. Ann Otol Rhinol Laryngol,2001,110:982-984.
  • 10Nicolson GL. Tumor cell instability, diversification, and progression to the metastatic phenotype : from oncogene to oncofetal expression. Cancer Res, 1987,47:1473-1487.

共引文献62

同被引文献57

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部